SIC
DRUG

SJS Investment Consulting’s Bright Minds Biosciences DRUG Stock Holding History

SJS Investment Consulting’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351 Buy
+5
New +$393 ﹤0.01% 2362

Other funds holding DRUG

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SJS Investment Consulting's DRUG Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Bright Minds Biosciences (DRUG) in Q2 2026: 5 shares worth $351. The stake represents ﹤0.01% of the portfolio and ranks #2362 among its holdings.

8 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • SJS Investment Consulting held 5 shares of Bright Minds Biosciences worth $351 as of Q2 2026.
  • Bright Minds Biosciences was a new SJS Investment Consulting position in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2362 holding.
  • 8 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.